Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/vincristine in Relapsed/refractory Aggressive B-cell Lymphoma
Kelly, Kevin R, Friedberg, Jonathan W., Park, Steven I, McDonagh, Kevin T, Hayslip, John, Persky, Daniel, Ruan, Jia, Puvvada, Soham, Rosen, Peter J., Padmanabhan Iyer, Swaminathan, Stefanovic, AlexandLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-18-0286
Date:
August, 2018
File:
PDF, 758 KB
english, 2018